QGel, a biomaterials company with advanced solutions for pharmaceutical drug discovery, announced today the closing of a $12 million financing in new capital.
12 Dec 2016
Lausanne, Switzerland

QGel said Dec. 12 that it closed a $12 million financing round. The round was led by new private investors, and includes continued participation from existing investors.

Continue reading…

Back to News and Media